Pure Global
NCT06310980

Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.

Pilot Study in Order to Verify the Effect of the Use of a Smartpen Coordinated With a Continuous Glucose Sensor by a Dedicated App, in a Group of Adolescents in Not Good Control: Sensor Augmented Smartpen.
Giulio Frontino·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 1
Drug/Device/Intervention
smartpen
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Giulio Frontino
Funder
IRCCS San Raffaele
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2025
Enrollment
34 participants
Primary outcome

Time in range

Summary

The Aim of this interventional study in to assess the effect of the use of a smartpen
 connected by an APP to continuous glucose sensors in a cohort of diabetic adolescents in not
 good metabolic control.
 
 Primary endpoint: time in range Secondary endpoints: other glucometrics, Hba1c, treatment
 satisfaction.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06310980
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06310980 through Pure Global AI's free database. This phase not specified trial is sponsored by Giulio Frontino and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 34 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.